Annual Drug Patent Expirations for DIFICID
Dificid is a drug marketed by Cubist Pharms Llc and is included in two NDAs. It is available from one supplier. There are six patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for DIFICID.
The generic ingredient in DIFICID is fidaxomicin. One supplier is listed for this compound. Additional details are available on the fidaxomicin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
